Allows initiation of the NRX-101 commercial development to treat Chronic Pain Company plans to seek Fast Track and Breakthrough Therapy Designations from FDA while awaiting near-term results of Dept of Defense-funded trial RADNOR, Pa., Oct. 2, 2023 /PRNewswire/ — NRx Pharmaceuticals, Inc….